Expertise/Certifications: Surgical Pathology, Gastrointestinal (GI) Pathology, Anatomic Pathology, Molecular Diagnostics
Office number: 444-7688
(Lab Customer Service: 401-793-4242)
Dr. Murray Resnick is the Pathologist-In-Chief at the Lifespan Medical Center and is Professor of Pathology and Laboratory Medicine at Brown University School of Medicine. Dr. Resnick received his M.D. and Ph.D. degrees from Hadassah Medical School, Hebrew University, in Jerusalem. He completed his residency in pathology and GI pathology fellowship training at the Brigham and Women's Hospital in Boston and pediatric pathology fellowship at the Childrens Hospital in Boston . His research interests are biomarkers of gastrointestinal tumors, Non-Alcoholic Steatohepatitis and the use of AI in diagnostic and translational pathology. .
|Acosta-Gonzalez, Gabriel, Ouseph, Madhu, Lombardo, Kara, Lu, Shaolei, Glickman, Jonathan, Resnick, Murray. "Immune environment in serrated lesions of the Colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression." Human Pathology, 2018.|
|"USCAP 2018 Abstracts: Gastrointestinal Pathology (657–893)." Modern Pathology, vol. 31, 2018, pp. 240-322.|
|Lu, Shaolei, Herzlinger, Michael, Cao, Weibiao, Noble, Lelia, Yang, Dongfang, Shapiro, Jason, Kurtis, Jonathan, LeLeiko, Neal, Resnick, Murray. "Utility of 15(S)-HETE as a Serological Marker for Eosinophilic Esophagitis." Scientific Reports, vol. 8, no. 1, 2018, pp. 14498.|
|Mangray, Shamlal, Breese, Virginia, Jackson, Cynthia L., Lombardo, Kara, Taliano, Ross, Resnick, Murray, Yakirevich, Evgeny. "Application of BRAF V600E Mutation Analysis for the Diagnosis of Metanephric Adenofibroma." The American Journal of Surgical Pathology, vol. 39, no. 9, 2015, pp. 1301-1304.|
1) Analysis of novel diagnostic and prognostic markers in gastrointestinal malignancies using molecular techniques;
2) Developing machine learning algorithms to assist pathologists and translational researchers. Focus areas include inflammatory bowel disease, Non-Alcoholic Steatohepatitis and immunoncology
COBRE Center for Cancer Research Development
#5 P20 GM103421 Molecular Pathology CoreNational Institutes of Health/National Institute of General Medical Sciences 09/30/02 – 04/30/14 NCE Role: Co-Investigator
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2 Overexpressing Esophageal Adenocarcinoma
#RTOG-1010 National Institutes of Health NCI CTROC BIQSFP Radiation Therapy Oncology Group
Role: Co-Principal Investigator
Single Agent Adjuvant Aflibercept for Patients with Resected or Ablated Metastatic Colorectal Cancer: A Randomized Phase II Study #BrUOG-261 SANOFI
Lu S, Mukkada VA, Mangray S, Cleveland K, Shillingford N, et al (2012) MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post glucocorticoid steroid treatment and relationship with mRNA target expression. PLoS One 7:e40676
Cao W, Tian W, Hong J, Li D, Tavares R, et al (2013) Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Phys Gast and Liver 304:G322-27.
Lu S, Singh K, Magray S, Tavares R, Nobel L, et al (2013) Claudin expression in high grade invasive ductal carcinoma of the breast. Mod Pathol 26:485-95.
Matoso A, Mukkada V, Lu S Monahan R, Cleveland K, Noble L, Mangray S, Resnick MB. (2013) Expression microarray analysis identifies novel epithelial derived proteins in eosinophilic esophagitis. Mod Pathol 26:665-672.
Taliano RJ, Lu S, Singh K, Mangray S, Tavares R, Nobel L, et al (2013) Calretinin expression in high grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis. Human Pathology 44:2743-50.
Matoso A, Allen D, Herzlinger M, Ferreira J, Chen S, Lu S, et al (2014) Correlation of ALOX15 expression with eosinophilic or reflux esophagitis in a cohort of pediatric patients with esophageal eosinophilia. Human Pathology (accepted for publication).
Sargent DJ, Shi Q, Gill S, Louvet C, Everson RB, Kellner U, et al (2014) Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study. Clin Can Res (accepted for publication).
Ronald DeLellis Mentoring Award, Department of Pathology and Laboratory Medicine,
Brown University Medical School 2012
Certificate of Recognition, Exemplary Teaching, Brown Medical School 2009-2010
Dean’s Teaching Excellence Award, Brown Medical School 2008-2009
Dean’s Teaching Excellence Award, Brown Medical School 2005-2006
Dean’s Teaching Excellence Award, Brown Medical School 2004-2005
Listed in Best Doctors in America 2007-present
Fulver Foundation Scholarship for excellence in studies, 1985
Foulkes Foundation Scholarship for excellence in studies, 1984-1987
2005-present Professor of Pathology Brown University Medical School, Providence, RI
2002-2005 Associate Professor of Pathology, Brown University Medical School, Providence, RI
1997-2002 Senior Lecturer Basic Sciences, Technion Medical School, Haifa, Israel
1990-1995 Clinical and Research Fellow, Harvard Medical School, Boston, MA
2022-present Pathologist-in-Chief, Lifespan Medical Center
2012-2019 Vice Chief of Pathology and Director of Anatomical Pathology, Rhode Island Hospital and The Miriam Hospital, Providence, RI
2010-2012 Interim Chief of Pathology, Rhode Island Hospital and The Miriam Hospital, Providence, RI
2003-present Director of Surgical Pathology, Rhode Island Hospital and The Miriam Hospital, Providence, RI
2002-present Director of Gastrointestinal Pathology, Rhode Island Hospital and The Miriam Hospital, Providence, RI
1999-2001 Consultant Pathologist, Brigham and Women’s Hospital and Childrens Hospital, Boston, MA
1997-2002 Director, Department of Pathology, Carmel Medical Center, Haifa, Israel
1996-1997 Director of Gastrointestinal Pathology Unit, Carmel Medical Center, Haifa, Israel
1995-1996 Senior Pathologist, Sourasky Medical Center, Tel-Aviv, Israel
2019-2022 Chief of Pathology, PATH-AI, Boston, MA
1999-2002 Medical Advisor, Proteologics, Rehovot, Israel
Membership in Societies:
American Association of Directors of Surgical Pathologists
American Gastroenterological Association
United States and Canadian Academy of Pathology
Roger Haggitt Gastrointestinal Pathology Society
Arthur Purdy Stout Society of Pathology
American Association for Cancer Research
2003-present Director, Gastrointestinal Pathology Fellowship Program, Rhode Island Hospital
2003-2009 Director Surgical Pathology Fellowship Program, Rhode Island Hospital
2002-present Pathology Residents, Rhode Island Hospital, approx. five one-hour teaching sessions per year, 12 students
2002-present Gastrointestinal (Medicine) Fellows, Rhode Island Hospital, one month tutorial per fellow, per year (2-3 fellows per year)
2002-present Pathology Residents and Fellows, Rhode Island Hospital, approximately 250 hours of direct microscopy training sessions each year.